Alloksys Life Sciences B.V.   Report issue

For profit Phase 1 Phase 3
Founded: Wageningen Netherlands (2005)
Status: Left NME R&D (2022)

Organization Overview

First Clinical Trial
2011
NCT01416493
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Alloksys Life Sciences BV . President

Active Ingredients

Drugs in Phase 3 Trials (1)

bovine intestinal alkaline phosphatase (2 trials)

Drugs in Phase 1 Trials (1)

hrescap (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 2)

Arthritis, Rheumatoid (Phase 2)

Inflammation (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 2